{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-001710","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.525467+00:00","generated_at":"2026-05-16T23:37:56.993836+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago","bullets":["Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.","Revenue fell 21.6% to $6.9M; gross margin dropped to 39.1% from 59.1%.","Shipped 16 SRT systems (vs 27 last year), including 3 to China; 21 FDA sites active.","CMS published first-ever dedicated CPT® codes for SRT, improving reimbursement certainty.","Exited quarter with $24.5M cash, no debt; nearly 100 systems in inventory."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-001710","json":"https://secwatch.observer/filing/0001753926-25-001710.json","markdown":"https://secwatch.observer/filing/0001753926-25-001710.md","text":"https://secwatch.observer/filing/0001753926-25-001710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/0001753926-25-001710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/g084998_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:37:56.993836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}